Literature DB >> 23166161

TRIF mediates Toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferi.

Tanja Petnicki-Ocwieja1, Erin Chung, David I Acosta, Laurie T Ramos, Ok S Shin, Sanjukta Ghosh, Lester Kobzik, Xin Li, Linden T Hu.   

Abstract

TRIF is an adaptor molecule important in transducing signals from intracellularly signaling Toll-like receptor 3 (TLR3) and TLR4. Recently, TLR2 was found to signal from intracellular compartments. Using a synthetic ligand for TLR2/1 heterodimers, as well as Borrelia burgdorferi, which is a strong activator of TLR2/1, we found that TLR2 signaling can utilize TRIF. Unlike TRIF signaling by other TLRs, TLR2-mediated TRIF signaling is dependent on the presence of another adaptor molecule, MyD88. However, unlike MyD88 deficiency, TRIF deficiency does not result in diminished control of infection with B. burgdorferi in a murine model of disease. This appears to be due to the effects of MyD88 on phagocytosis via scavenger receptors, such as MARCO, which are not affected by the loss of TRIF. In mice, TRIF deficiency did have an effect on the production of inflammatory cytokines, suggesting that regulation of inflammatory cytokines and control of bacterial growth may be uncoupled, in part through transduction of TLR2 signaling through TRIF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23166161      PMCID: PMC3553797          DOI: 10.1128/IAI.00890-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

2.  Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi.

Authors:  R Mark Wooten; Ying Ma; R Alyson Yoder; Jeanette P Brown; John H Weis; James F Zachary; Carsten J Kirschning; Janis J Weis
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

3.  Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Authors:  Masahiro Yamamoto; Shintaro Sato; Kiyotoshi Mori; Katsuaki Hoshino; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

4.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

6.  Tumor necrosis factor-alpha -mediated protein kinases in regulation of scavenger receptor and foam cell formation on macrophage.

Authors:  H Y Hsu; Y C Twu
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

7.  TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.

Authors:  Vladimir Toshchakov; Bryan W Jones; Pin-Yu Perera; Karen Thomas; M Joshua Cody; Shuling Zhang; Bryan R G Williams; Jennifer Major; Thomas A Hamilton; Matthew J Fenton; Stefanie N Vogel
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

8.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.

Authors:  Hiroyuki Oshiumi; Misako Matsumoto; Kenji Funami; Takashi Akazawa; Tsukasa Seya
Journal:  Nat Immunol       Date:  2003-01-21       Impact factor: 25.606

9.  Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice.

Authors:  Lena Alexopoulou; Venetta Thomas; Markus Schnare; Yves Lobet; Juan Anguita; Robert T Schoen; Ruslan Medzhitov; Erol Fikrig; Richard A Flavell
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

10.  CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Authors:  Bikash Sahay; Rebeca L Patsey; Christian H Eggers; Juan C Salazar; Justin D Radolf; Timothy J Sellati
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more
  34 in total

1.  Adaptor Protein-3-Mediated Trafficking of TLR2 Ligands Controls Specificity of Inflammatory Responses but Not Adaptor Complex Assembly.

Authors:  Tanja Petnicki-Ocwieja; Aurelie Kern; Tess L Killpack; Stephen C Bunnell; Linden T Hu
Journal:  J Immunol       Date:  2015-09-30       Impact factor: 5.422

2.  Phagocytic Receptors Activate Syk and Src Signaling during Borrelia burgdorferi Phagocytosis.

Authors:  Tess L Killpack; Maria Ballesteros; Stephen C Bunnell; Alice Bedugnis; Lester Kobzik; Linden T Hu; Tanja Petnicki-Ocwieja
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

3.  TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia.

Authors:  Kevin G Burfeind; Xinxia Zhu; Peter R Levasseur; Katherine A Michaelis; Mason A Norgard; Daniel L Marks
Journal:  Brain Behav Immun       Date:  2018-05-28       Impact factor: 7.217

4.  MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease.

Authors:  Christine J Hastey; Jennine Ochoa; Kimberley J Olsen; Stephen W Barthold; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

Review 5.  TLR5 expression in the small intestine depends on the adaptors MyD88 and TRIF, but is independent of the enteric microbiota.

Authors:  Inês Brandão; Nives Hörmann; Sven Jäckel; Christoph Reinhardt
Journal:  Gut Microbes       Date:  2015-04-29

Review 6.  Microbe-inducible trafficking pathways that control Toll-like receptor signaling.

Authors:  Yunhao Tan; Jonathan C Kagan
Journal:  Traffic       Date:  2016-11-23       Impact factor: 6.215

Review 7.  The Jarisch-Herxheimer Reaction After Antibiotic Treatment of Spirochetal Infections: A Review of Recent Cases and Our Understanding of Pathogenesis.

Authors:  Thomas Butler
Journal:  Am J Trop Med Hyg       Date:  2016-10-24       Impact factor: 2.345

Review 8.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

9.  Activation of TRIF-dependent and independent immune responses by neisserial heat shock protein complex vaccines.

Authors:  Garrett Z Ng; Jia-Xi Han; Camilo A Colaco; Philip Sutton
Journal:  Hum Vaccin Immunother       Date:  2016-06-20       Impact factor: 3.452

10.  Outer surface protein OspC is an antiphagocytic factor that protects Borrelia burgdorferi from phagocytosis by macrophages.

Authors:  Sebastian E Carrasco; Bryan Troxell; Youyun Yang; Stephanie L Brandt; Hongxia Li; George E Sandusky; Keith W Condon; C Henrique Serezani; X Frank Yang
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.